Board Meeting Details

The Board of Directors meeting was held on Monday, November 02, 2026, commencing at 11:30 AM IST and concluding at 12:20 PM IST. The board approved the standalone unaudited financial results for the quarter and half-year ended September 30, 2026, and took on record the Limited Review Report thereon.

Financial Results Overview

Quarterly Performance (Q2 FY27 vs Q1 FY27 vs Q2 FY26)

  • Total Revenue: ₹228.00 lakh (Q2 FY27) vs ₹109.54 lakh (Q1 FY27) vs ₹47.40 lakh (Q2 FY26)
  • Revenue from Operations: ₹227.32 lakh, comprising:
  • Interest Income: ₹74.02 lakh
  • Dividend Income: ₹1.21 lakh
  • Fees and Commission Income: ₹6.34 lakh
  • Net gain on fair value changes/Realised Capital Gain: ₹145.76 lakh
  • Other operating income: ₹0.00 lakh
  • Other Income: ₹0.68 lakh
  • Total Expenses: ₹220.73 lakh, including:
  • Finance costs: ₹0.03 lakh
  • Impairment on financial instrument: ₹211.48 lakh
  • Employee benefits expense: ₹8.14 lakh
  • Other expenses: ₹1.08 lakh
  • Profit Before Tax: ₹7.28 lakh
  • Tax Expense: ₹(19.95) lakh
  • Net Profit: ₹7.83 lakh
  • Earnings Per Share (Basic & Diluted): ₹0.02

Half-Year Performance (H1 FY27 vs H1 FY26)

  • Total Revenue: ₹337.54 lakh (H1 FY27) vs ₹138.50 lakh (H1 FY26)
  • Profit Before Tax: ₹70.03 lakh
  • Net Profit: ₹55.18 lakh
  • Earnings Per Share (Basic & Diluted): ₹0.12

Balance Sheet Position (as at September 30, 2026)

  • Total Assets: ₹4,257.34 lakh
  • Financial Assets: ₹4,224.79 lakh, including:
  • Cash and cash equivalents: ₹10.28 lakh
  • Loans: ₹2,295.52 lakh
  • Investments: ₹0.00 lakh
  • Other Financial Assets: ₹65.58 lakh
  • Receivables: ₹0.24 lakh
  • Non-Financial Assets: ₹32.55 lakh
  • Total Liabilities: ₹23.63 lakh
  • Equity: ₹4,233.71 lakh, comprising:
  • Equity Share Capital: ₹462.50 lakh (increased from ₹185.00 lakh as of March 31, 2026)
  • Other Equity: ₹3,771.21 lakh

Cash Flow Statement (Half-Year Ended September 30, 2026)

  • Net cash used in operating activities: ₹(1,094.19) lakh
  • Net cash used in investing activities: ₹(1,691.61) lakh
  • Net cash from financing activities: ₹2,754.82 lakh
  • Net decrease in cash and cash equivalents: ₹(31.29) lakh
  • Cash and cash equivalents at period end: ₹10.28 lakh

Key Financial Metrics

  • Paid-up share capital: ₹462.50 lakh (face value ₹1 per share)
  • Significant impairment charge: ₹211.48 lakh in Q2 FY27 on financial instruments
  • **Tax adjustments include prior year tax expense of ₹20.51 lakh in Q2 FY27

Additional Information

  • Corporate Office: 2nd Floor, C 373 Behind Amar Jain Hospital, Block C, Vaishali Nagar, Jaipur-302021, Rajasthan
  • Company Identification Number: L51900MH1986PLC041499